XML 27 R11.htm IDEA: XBRL DOCUMENT v2.3.0.15
Financial Instruments and Fair Value Measurement
9 Months Ended
Sep. 30, 2011
Fair Value Disclosures [Abstract] 
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENT
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENT

The Company enters into derivative instruments for risk management purposes only, including derivatives designated as hedging instruments under the Derivatives and Hedging topic of the FASB Codification and those not designated as hedging instruments under this guidance. The Company uses interest rate swaps, natural gas swap contracts, and forward exchange contracts. These derivative instruments are designated as cash flow hedges and, to the extent they are effective in offsetting the variability of the hedged cash flows, changes in the derivatives’ fair value are not included in current earnings but are included in Accumulated Other Comprehensive Loss. These changes in fair value will subsequently be reclassified to earnings.

Interest Rate Risk

The Company uses interest rate swaps to manage interest rate risks on future interest payments caused by interest rate changes on its variable rate term loan facility. The differential to be paid or received under these agreements is recognized as an adjustment to Interest Expense related to debt. At September 30, 2011 and December 31, 2010, the Company had interest rate swap agreements with a notional amount of $920 million and $1,250 million, respectively. The outstanding swap agreements, under which the Company will pay fixed rates of 2.24% to 3.84% and receive three-month LIBOR rates, expire on various dates in 2012.

Changes in fair value will subsequently be reclassified into earnings as a component of Interest Expense, Net as interest is incurred on amounts outstanding under the term loan facility. Ineffectiveness measured in the hedging relationship is recorded in earnings in the period it occurs.

During the first nine months of 2011 and 2010, there were no amounts or minimal amounts of ineffectiveness related to changes in the fair value of interest rate swap agreements. Additionally, there were no amounts excluded from the measure of effectiveness.

Commodity Risk

To manage risks associated with future variability in cash flows and price risk attributable to certain commodity purchases, the Company enters into natural gas swap contracts to hedge prices for a designated percentage of its expected natural gas usage. The Company has entered into natural gas swap contracts to hedge pricing for approximately 70% of its expected natural gas usage for the remainder of 2011, with a weighted average contractual rate of $4.79 per one million British Thermal Units (“MMBTUs”), and for 40% of its expected natural gas usage for the first quarter of 2012, with a weighted average contractual price of $4.84 per MMBTU. Such contracts are designated as cash flow hedges. The contracts are carried at fair value with changes in fair value recognized in Accumulated Other Comprehensive Loss, and the resulting gain or loss is reclassified into Cost of Sales concurrently with the recognition of the commodity consumed. The ineffective portion of the swap contracts’ change in fair value would be recognized immediately in earnings.

During the first nine months of 2011 and 2010, there were minimal amounts of ineffectiveness related to changes in the fair value of natural gas swap contracts. Additionally, there were no amounts excluded from the measure of effectiveness.

Foreign Currency Risk

The Company enters into forward exchange contracts to manage risks associated with future variability in cash flows resulting from anticipated foreign currency transactions that may be adversely affected by changes in exchange rates. Such contracts are designated as cash flow hedges. The contracts are carried at fair value with changes in fair value recognized in Accumulated Other Comprehensive Loss, and gains/losses related to these contracts are recognized in Other Income, Net when the anticipated transaction affects income. At September 30, 2011, multiple forward exchange contracts existed that expire on various dates through 2012. Those purchased forward exchange contracts outstanding at September 30, 2011 and December 31, 2010, when aggregated and measured in U.S. dollars at contractual rates at September 30, 2011 and December 31, 2010 had notional amounts totaling $21.3 million and $58.7 million, respectively.

No amounts were reclassified to earnings during the first nine months of 2011 or during 2010 in connection with forecasted transactions that were no longer considered probable of occurring, and there was no amount of ineffectiveness related to changes in the fair value of foreign currency forward contracts. Additionally, there were no amounts excluded from the measure of effectiveness.

Derivatives not Designated as Hedges

The Company enters into forward exchange contracts to effectively hedge substantially all of its accounts receivable resulting from sales transactions denominated in foreign currencies in order to manage risks associated with foreign currency transactions adversely affected by changes in exchange rates. At September 30, 2011 and December 31, 2010, multiple foreign currency forward exchange contracts existed, with maturities ranging up to three months. Those foreign currency exchange contracts outstanding at September 30, 2011 and December 31, 2010, when aggregated and measured in U.S. dollars at exchange rates at September 30, 2011 and December 31, 2010, had net notional amounts totaling $23.7 million and $8.2 million, respectively. Unrealized gains and losses resulting from these contracts are recognized in Other Income, Net and approximately offset corresponding recognized but unrealized gains and losses on these accounts receivable.


Fair Value of Financial Instruments

The Company’s derivative instruments are carried at fair value. The Company has determined that the inputs to the valuation of these derivative instruments are level 2 in the fair value hierarchy. Level 2 inputs are defined as quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. The Company uses valuation techniques based on discounted cash flow analyses, which reflects the terms of the derivatives and uses observable market-based inputs, including forward rates and uses market price quotations obtained from independent derivatives brokers, corroborated with information obtained from independent pricing service providers.

As of September 30, 2011, there has not been any significant impact to the fair value of the Company’s derivative liabilities due to its own credit risk. Similarly, there has not been any significant adverse impact to the Company’s derivative assets based on evaluation of the Company’s counterparties’ credit risks.

The fair value of the Company’s derivative instruments is as follows:


 
Derivative Assets
 
Derivative Liabilities
In millions
Balance Sheet
Location
 
September 30,
2011
 
December 31,
2010
 
Balance Sheet
Location
 
September 30,
2011
 
December 31,
2010
Derivative Contracts Designated as Hedging Instruments
 
 
 
 
 
 
 
 
 
 
 
Commodity Contracts
Other Current Assets
 

$—

 

$0.1

 
Other Accrued Liabilities
 

$2.2

 

$0.8

Foreign Currency Contracts
Other Current Assets
 
0.2

 
0.7

 
Other Accrued Liabilities
 
0.8

 
0.6

Interest Rate Swap Agreements

Other Current Assets

 

 

 
Other Accrued Liabilities and Interest Payable
 
13.9

 
33.3

Derivative Contracts Not Designated as Hedging Instruments
 
 
 
 
 
 
 
 
 
 
 
Foreign Currency Contracts
Other Current Assets
 
0.8

 

 
Other Accrued Liabilities
 

 
0.3

Total Derivative Contracts
 
 

$1.0

 

$0.8

 
 
 

$16.9

 

$35.0


The fair values of the Company’s other financial assets and liabilities at September 30, 2011 and December 31, 2010 approximately equal the carrying values reported on the Consolidated Balance Sheets except for Long-Term Debt. The fair value of the Company’s Long-Term Debt was $2,371.7 million and $2,626.8 million as compared to the carrying amounts of $2,355.6 million and $2,572.4 million as of September 30, 2011 and December 31, 2010, respectively. The fair value of Long-Term Debt is based on quoted market prices.

Effect of Derivative Instruments

The effect of derivative instruments in cash flow hedging relationships on the Company’s Consolidated Statements of Operations is as follows:
 
Amount of Loss (Gain) Recognized in Accumulated Other Comprehensive Loss
 
Location in Statement of Operations (Effective Portion)
 
Amount of Loss (Gain) Recognized in Statement of Operations (Effective Portion)
 
Location in Statement of Operations (Effective Portion)
 
Amount of (Gain) Recognized in Statement of Operations (Ineffective Portion)
 
 
 
 
 
Three Months Ended
 
 
Three Months Ended
 
 
Three Months Ended
 
September 30,
 
 
September 30,
 
 
September 30,
In millions
2011
 
2010
 
 
2011
 
2010
 
 
2011
 
2010
Commodity Contracts

$2.4

 

$4.2

 
Cost of Sales
 

$0.4

 

$1.3

 
Cost of Sales
 

$—

 

($0.1
)
Foreign Currency Contracts
0.3

 
1.6

 
Other (Income) Expense, Net
 
0.6

 
(1.0
)
 
Other (Income) Expense, Net
 

 

Interest Rate Swap Agreements
(0.2
)
 
6.8

 
Interest Expense, Net
 
5.6

 
8.3

 
Interest Expense, Net
 

 

Total

$2.5

 

$12.6

 
 
 

$6.6

 

$8.6

 
 
 

$—

 

($0.1
)


 
Amount of Loss (Gain) Recognized in Accumulated Other Comprehensive Loss
 
Location in Statement of Operations (Ineffective Portion)
 
Amount of Loss (Gain) Recognized in Statement of Operations (Effective Portion)
 
Location in Statement of Operations (Ineffective Portion)
 
Amount of (Gain) Recognized in Statement of Operations (Ineffective Portion)
 
Nine Months Ended
 
 
Nine Months Ended
 
 
Nine Months Ended
 
September 30,
 
 
September 30,
 
 
September 30,
In millions
2011
 
2010
 
 
2011
 
2010
 
 
2011
 
2010
Commodity Contracts

$3.9

 

$9.8

 
Cost of Sales
 

$2.5

 

$3.4

 
Cost of Sales
 

$—

 

$—

Foreign Currency Contracts
2.3

 
(0.1
)
 
Other (Income) Expense, Net
 
1.1

 
(0.5
)
 
Other (Income) Expense, Net
 

 

Interest Rate Swap Agreements
1.5

 
24.4

 
Interest Expense, Net
 
18.7

 
26.8

 
Interest Expense, Net
 

 
(0.2
)
Total

$7.7

 

$34.1

 
 
 

$22.3

 

$29.7

 
 
 

$—

 

($0.2
)

The effect of derivative instruments not designated as hedging instruments on the Company’s Condensed Consolidated Statements of Operations is as follows:

 
 
Three Months Ended
Nine Months Ended
 
 
 September 30,
September 30,
In millions
 
2011
2010
2011
2010
Foreign Currency Contracts
Other (Income) Expense, Net
$(1.6)
$1.8
$(0.2)
$1.4

Accumulated Derivative Instruments (Loss) Gain

The following is a rollforward of Accumulated Derivative Instruments (Loss) Gain which is included in the Company’s Condensed Consolidated Balance Sheets:

In millions
 
Balance at December 31, 2010
$(27.4)
Reclassification to earnings
22.3

Current period change in fair value
(7.7
)
Balance at September 30, 2011
$(12.8)

At September 30, 2011, the Company expects to reclassify approximately $12.8 million of losses in the next twelve months from Accumulated Other Comprehensive Loss to earnings, contemporaneously with and offsetting changes in the related hedged exposure. The actual amount that will be reclassified to future earnings may vary from this amount as a result of changes in market conditions.